Literature DB >> 31478404

Silicone Oil Tamponade in Rhegmatogenous Retinal Detachment: Functional and Morphological Results.

Katharina Eibenberger1, Stefan Sacu1, Sandra Rezar-Dreindl1, Ursula Schmidt-Erfurth1, Michael Georgopoulos1.   

Abstract

Purpose: To evaluate the functional and morphological outcomes of patients with SO tamponade due to primary rhegmatogenous retinal detachment (primRD) and recurrent rhegmatogenous detachment (recRD).
Methods: Seventy-five eyes were enrolled in this prospective study between January 2009 and December 2016. Patients with primRD and recRD were evaluated in a complete ophthalmic examination including best-corrected visual acuity (BCVA) and OCT before and after silicone oil removal (SOR).
Results: The primRD group comprised 35 eyes and the recRD group 40 eyes with a duration of SO tamponade of 9 ± 4/12 ± 11 months in the primRD/recRD groups (p = .088). The preoperative OCT revealed a high rate of morphological changes such as ERM (primRD: 24%; recRD: 69%) and CME (primRD: 10%; recRD: 55%) in the recRD compared with the primRD group (ERM: p = .18; CME: p = .04). No such difference was observed postoperatively. Disruption of the ellipsoid zone (EZ) was similar in both groups (primRD: 52%; recRD: 72%) before SOR and was restored in 66%/58% (primRD/recRD) after SOR. No difference was found regarding pre- and postoperative VA (0.91 ± 0.54/0.90 ± 0.54logMAR primRD/recRD preoperative; 0.76 ± 0.56/0.71 ± 0.53logMAR primRD/recRD at the last follow-up; p = .96/p = .70). EZ integrity (0.43 ± 0.31logMAR) was associated with better functional results than an interrupted EZ (0.86 ± 0.43logMAR; p < .001). A significant positive correlation of the duration of SO tamponade and the final VA was found in the primRD (r = 0.396, p = .02) whereas none in the recRD group (r = 0.196; p = .31).
Conclusion: Morphological changes including ERM and CME were more pronounced in the recRD group, but only before SOR. Interestingly, the pre- and postoperative BCVA were similar in both groups with EZ integrity being a factor of good functional outcome. The duration of SO tamponade had a statistically significant negative impact on the postoperative VA in the primary detachments.

Entities:  

Keywords:  Rhegmatogenous retinal detachment; epiretinal membrane; macular edema; optical coherence tomography; silicone oil tamponade

Mesh:

Substances:

Year:  2019        PMID: 31478404     DOI: 10.1080/02713683.2019.1652917

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  5 in total

1.  Longitudinal evaluation of retinal thickness and OCTA parameters before and following silicone oil removal in eyes with macula-on and macula-off retinal detachments.

Authors:  Zerrin Bayraktar; Seren Pehlivanoglu; Samira Hagverdiyeva; Sinan Albayrak; Muharrem Karakaya; Şükrü Bayraktar
Journal:  Int Ophthalmol       Date:  2022-01-08       Impact factor: 2.031

2.  LONGITUDINAL ELLIPSOID ZONE AND OUTER RETINAL INTEGRITY DYNAMICS AFTER EPIRETINAL MEMBRANE SURGERY.

Authors:  Tisileli S Tuifua; Joseph R Abraham; Sunil K Srivastava; Peter K Kaiser; Jamie Reese; Justis P Ehlers
Journal:  Retina       Date:  2022-02-01       Impact factor: 4.256

3.  Peripapillary Vessel Density in Eyes with Rhegmatogenous Retinal Detachment after Pars Plana Vitrectomy.

Authors:  Bing Lu; Pengfei Zhang; Haiyun Liu; Huixun Jia; Yang Yu; Fenghua Wang; Hong Wang; Xiaodong Sun
Journal:  J Ophthalmol       Date:  2021-03-23       Impact factor: 1.909

4.  Evaluation of the Effects of Silicone Oil on the Macula with Optical Coherence Tomography in Patients with Rhegmatogenous Retinal Detachment

Authors:  Duygu Er; Hakan Öner; Mahmut Kaya; Oya Dönmez
Journal:  Turk J Ophthalmol       Date:  2021-08-27

Review 5.  Retinal and Corneal Changes Associated with Intraocular Silicone Oil Tamponade.

Authors:  Mariantonia Ferrara; Giulia Coco; Tania Sorrentino; Kirti M Jasani; George Moussa; Francesco Morescalchi; Felipe Dhawahir-Scala; Francesco Semeraro; David H W Steel; Vito Romano; Mario R Romano
Journal:  J Clin Med       Date:  2022-09-05       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.